spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  CT  


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 5 Dec 2025
Olympus, Gore, and ConMed Announce Transition of Commercial Support for the GORE(R) VIABIL(R) Biliary Endoprosthesis in the United States
Devices Distribution
 HSMN NewsFeed - 4 Dec 2025
SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 3 Dec 2025
Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty
Devices Orthopaedic
 HSMN NewsFeed - 2 Dec 2025
CMS Finalizes OPPS Payment for Eko Health's SENSORA(R) Platform, Expanding Reimbursement for AI-Enabled Cardiac Disease Detection in Hospital-Associated Outpatient Care
Devices Cardiology Reimbursement
 HSMN NewsFeed - 1 Dec 2025
Morphocell Technologies Completes US$50 Million Series A Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 28 Nov 2025
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Nov 2025
Restore Medical Appoints Former Medtronic Executive Chris Cleary as Chairman of the Board
Devices Cardiology Personnel
 HSMN NewsFeed - 25 Nov 2025
Medicare Finalizes Reimbursement for Caristo's CaRi-Plaque(TM) Across Hospital and Office Settings
Diagnostics Cardiology Reimbursement
 HSMN NewsFeed - 24 Nov 2025
Hollister Incorporated Drives Major Policy Change to Expand Access to Closed System Intermittent Catheters for People with Spinal Cord Injuries
Devices Urology Regulatory
 HSMN NewsFeed - 20 Nov 2025
Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 19 Nov 2025
CMS Establishes National Pricing for Vesiflo's inFlow(TM) Voiding Prosthesis
Devices Urology Reimbursement
 HSMN NewsFeed - 18 Nov 2025
Piccolo Medical(R) Receives FDA Clearance to Expand ECGuide(TM) Technology Use to Pediatric and Neonatal Patients
Devices FDA
 HSMN NewsFeed - 17 Nov 2025
BD Onclarity(TM) HPV Assay for BD COR(TM) and BD Viper(TM) LT Systems Receive WHO Prequalification
Diagnostics Regulatory
 HSMN NewsFeed - 14 Nov 2025
Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA(R) Knee Robotic Technology
Devices Orthopaedic FDA
 HSMN NewsFeed - 13 Nov 2025
icotec Receives FDA Clearance for the CMORE(R) CT System, Expanding its BlackArmor(R) Engineered Carbon/PEEK Technology to the Posterior Cervicothoracic Spine
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 13 Nov 2025
HAPPE Spine Reaches 1,000 Patients with the INTEGRATE(R)-C Interbody Fusion System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 12 Nov 2025
BD Expands PureWick(TM) Portfolio with First-of-its-Kind Portable Solution to Confidently Manage Urinary Incontinence On the Go
Devices Urology Product Launch
 HSMN NewsFeed - 12 Nov 2025
Modulight Biotherapeutics Announces $12 Million Seed Funding for Novel Optogenetic Therapy to Treat Neurological Disorders
Devices Neurology Venture Capital
 HSMN NewsFeed - 10 Nov 2025
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 10 Nov 2025
Freenome Appoints Industry Veteran Rob Guigley as Chief Commercial Officer to Drive Commercial Strategy, As Agreement with Exact Sciences Clears Antitrust Review
Diagnostics Personnel
 HSMN NewsFeed - 7 Nov 2025
Laborie Announces Agreement to Acquire the JADA(R) System from Organon
Devices Acquisitions
 HSMN NewsFeed - 7 Nov 2025
Gore Announces Positive Clinical Trial Results of the Investigational Gore(R) Viabahn(R) Fortegra Venous Stent for Treatment of Patients With Deep Venous Iliocaval Obstruction
Devices Interventional
 HSMN NewsFeed - 5 Nov 2025
Volta Medical Brings Volta AF-Xplorer(TM) II to the U.S., Ushering in a New Era of AI in Ablation for Complex Atrial Fibrillation
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 5 Nov 2025
Braveheart Bio Launches with $185M Series A Aiming to Transform Care of Hypertrophic Cardiomyopathy
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 4 Nov 2025
Cathetrix to Launch Nephro-Safe for Nephrostomy Patients at MEDICA 2025
Devices Product Launch
 HSMN NewsFeed - 30 Oct 2025
Brenig Therapeutics Names Megan McGill as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 29 Oct 2025
CustoMED Announces $6M Funding to Scale AI-Powered 3D Printed Solutions for Orthopedic Surgery
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 28 Oct 2025
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
Devices Orthopaedic FDA
 HSMN NewsFeed - 28 Oct 2025
ViCentra Strengthens Leadership Team to Accelerate Growth
Devices Endocrinology Drug Delivery Personnel
 HSMN NewsFeed - 27 Oct 2025
Remedy Robotics and Mission Thrombectomy Announce Partnership to Expand Access to Thrombectomy for Stroke with Telerobotics
Devices Interventional Neurology
 HSMN NewsFeed - 27 Oct 2025
Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Oct 2025
Terumo Interventional Systems Announces Its New OPUSWAVE(R) Dual Sensor Imaging System and DualView(R) Imaging Catheter Receive FDA 510(k) Clearance
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 23 Oct 2025
Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings
Diagnostics Neurology
 HSMN NewsFeed - 22 Oct 2025
Oticon Introduces the World's Smallest Powerhouse: Oticon Intent(TM) miniBTE R with Two Fitting Levels
Devices Product Launch
 HSMN NewsFeed - 21 Oct 2025
Onkos Surgical(R) Receives FDA 510(k) Clearance for ELEOS(TM) Proximal Tibia with NanoCept(R) Antibacterial Technology
Devices Orthopaedic FDA
 HSMN NewsFeed - 21 Oct 2025
PleoPharma, Inc. Closes $36 Million Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Oct 2025
GRAIL, Inc. Announces $325.0 Million Private Placement Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 17 Oct 2025
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
Devices Neurology Mergers & Acquisitions
 HSMN NewsFeed - 14 Oct 2025
Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Oct 2025
Zeta Surgical(R) AI-powered TMS Navigation System Receives FDA 510(k) Clearance
Devices Neurology FDA
 HSMN NewsFeed - 10 Oct 2025
Next-Generation AI-Driven SyncAR(R) Spine Receives FDA Clearance for Spine Surgery
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 9 Oct 2025
Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Oct 2025
BD Reaches Major Milestone for Rotarex(TM) Catheter System with First Patient Enrolled in XTRACT(TM) Registry to Advance Real-World Evidence in Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 8 Oct 2025
Medtronic Initiates U.S. IDE Clinical Study Evaluating Hugo(TM) Robotic-Assisted Surgery System for Gynecological Procedures
Devices Surgery
 HSMN NewsFeed - 8 Oct 2025
Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Oct 2025
Cardinal Health Launches a New All-In-One Solution for Deep Vein Thrombosis and Pulmonary Embolism Prevention
Devices Product Launch
 HSMN NewsFeed - 6 Oct 2025
Alcresta Therapeutics Expands Executive Leadership to Drive Strategic Initiatives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Oct 2025
Koh Young to Showcase Next Gen Navigated Neurosurgical Robot at CNS Innovation Symposium
Devices Neurosurgery
 HSMN NewsFeed - 2 Oct 2025
Groundbreaking Therapy for Advanced Heart Failure: Repairon Completes Series A Financing to Expand the Clinical Development of Its Regenerative Heart Therapy
Regenerative Medicine Cardiology Venture Capital
 HSMN NewsFeed - 26 Sep 2025
Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care
Devices Oncology Product Launch
 HSMN NewsFeed - 25 Sep 2025
Sanolla Launches the World's First Smart AI-powered Stethoscope Offering Full-Spectrum Auscultation
Devices Product Launch
 HSMN NewsFeed - 24 Sep 2025
TSC Life Receives FDA 510(K) Clearance for Fluido(R) AirGuard System, a Moderate to High Flow Blood and IV Fluid Warming Solution for the Prevention of Hypothermia
Devices FDA
 HSMN NewsFeed - 23 Sep 2025
HSMN Announces Dual Product Launches: FindReps(R) and NewLines(TM) Apps Updated for Apple’s iOS 26
Devices Diagnostics Distribution Product Launch
 HSMN NewsFeed - 19 Sep 2025
Kelyniam Global, Inc. Receives FDA Clearance for Innovative Fusion(TM) BCP-PEEK Implant
Devices Neurosurgery FDA
 HSMN NewsFeed - 17 Sep 2025
Amber Implants Secures FDA 510(k) Clearance for VCFix(R) Spinal System: A Next-Generation Solution for Vertebral Compression Fractures
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 16 Sep 2025
Roche Receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App Integration, Offering an Enhanced Diabetes Management Experience
Devices Monitoring Regulatory
 HSMN NewsFeed - 15 Sep 2025
Resurfacing Just Changed Forever: Sciton Unveils HALO(R) TRIBRID(TM), the World's First Triple-Wavelength Resurfacing Laser
Devices Dermatology Product Launch
 HSMN NewsFeed - 11 Sep 2025
Laborie Appoints Chris Smith as Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 10 Sep 2025
Levita Magnetics Powers World's First AI-Guided Autonomous Surgery with MARS Platform
Devices Surgery
 HSMN NewsFeed - 8 Sep 2025
FDA Accepts Letter of Intent to Qualify LSM by VCTE (FibroScan(R)) as First Non-Invasive Surrogate Endpoint in MASH Clinical Trials
Diagnostics FDA
 HSMN NewsFeed - 5 Sep 2025
Roche Receives CE IVDR Approval for HER2 (4B5) Companion Diagnostic Test to Identify HER2-ultralow Breast Cancer and Biliary Tract Cancer Patients
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 4 Sep 2025
Sentec Receives FDA Clearance for LuMon(TM) Electrical Impedance Tomography (EIT) System -- First EIT System Indicated for Premature Infants and for Spontaneously Breathing Patients in the United States
Devices Monitoring FDA
 HSMN NewsFeed - 4 Sep 2025
4DMedical's CT:VQ(TM) Receives FDA 510(k) Clearance; First-and-Only CT-Based VQ Technology
Devices Radiology FDA
 HSMN NewsFeed - 3 Sep 2025
Terumo Neuro Unveils New SOFIA(TM) Flow 88 Neurovascular Aspiration Catheter Data from EMEA Demonstrating Strong Performance
Devices Interventional Neurology
 HSMN NewsFeed - 2 Sep 2025
Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 29 Aug 2025
Abbott's Navitor(TM) TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 28 Aug 2025
Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care
Devices Orthopaedic Personnel
 HSMN NewsFeed - 28 Aug 2025
Proton Center in South Korea Selects RayStation and RayCare
Devices Oncology
 HSMN NewsFeed - 27 Aug 2025
Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 27 Aug 2025
Large Independent Randomized Controlled Trial Validates MolecuLight's Transformative Impact on Wound Debridement, Showing Improved Outcomes and Lower Costs
Devices Wound Care
 HSMN NewsFeed - 26 Aug 2025
Ortho Development Announces Executive Leadership Changes
Devices Orthopaedic Personnel
 HSMN NewsFeed - 25 Aug 2025
ProVerum Secures $80 Million Series B Financing to Advance New Treatment for BPH
Devices Urology Venture Capital
 HSMN NewsFeed - 25 Aug 2025
Akeso Reports Phase 3 Trials Show Positive Results: Gumokimab (IL-17) for Ankylosing Spondylitis and Manfidokimab (IL-4R?) for Atopic Dermatitis Achieve Primary Endpoints
Biopharmaceuticals
 HSMN NewsFeed - 22 Aug 2025
Sonic Healthcare USA, Inc. Announces Acquisition of Cairo Diagnostics LLC to Expand Sonic's National Hematology Oncology Testing Capabilities
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 21 Aug 2025
FDA Clearance of Salix(R) Coronary Plaque Module
Devices Cardiology FDA
 HSMN NewsFeed - 20 Aug 2025
Anne White to Retire as Executive Vice President and President, Lilly Neuroscience
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 20 Aug 2025
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
Devices FDA
 HSMN NewsFeed - 19 Aug 2025
Medtronic Announces Board Appointments and Shareholder Value Creation Initiatives to Advance Strategic Priorities
Devices Personnel
 HSMN NewsFeed - 18 Aug 2025
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
Diagnostics Neurology Product Launch
 HSMN NewsFeed - 15 Aug 2025
Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Aug 2025
BTL Expands EMFACE(R) Indications with New FDA Clearance for TMJ Dysfunction
Devices FDA
 HSMN NewsFeed - 12 Aug 2025
U.S. Military Study Identifies TITAN CSR(R) Retractor as Top Surgical Retractor for Deployed Trauma Care
Devices Surgery
 HSMN NewsFeed - 11 Aug 2025
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Aug 2025
ulrich medical USA(R) Announces Full Market Launch of Cortium(R) Universal OCT Spinal Fixation System
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 5 Aug 2025
Hemispherian Receives FDA IND Clearance for First-in-Class Glioblastoma Therapeutic, GLIX1
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Aug 2025
BioMarin Announces Appointment of Ian T. Clark to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2025
Ultromics Lands $55M Series C to Tackle Undiagnosed Heart Failure at Scale
Devices Cardiology Venture Capital
 HSMN NewsFeed - 30 Jul 2025
BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test
Diagnostics FDA
 HSMN NewsFeed - 30 Jul 2025
MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology
Devices Gastroenterology Venture Capital
 HSMN NewsFeed - 29 Jul 2025
Leo Cancer Care Receives FDA 510(k) Clearance for Marie(R) - A Revolutionary Upright Radiotherapy Platform
Devices Oncology FDA
 HSMN NewsFeed - 28 Jul 2025
MapLight Therapeutics Announces $372.5 Million Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 28 Jul 2025
Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life
Devices Interventional Product Launch
 HSMN NewsFeed - 25 Jul 2025
RaySearch to Present Innovative News in RayStation, RayCare, and RayIntelligence at AAPM 2025
Devices Oncology
 HSMN NewsFeed - 23 Jul 2025
Neuros Medical Announces First Commercial Implant of the Altius(R) Direct Electrical Nerve Stimulation System, a Breakthrough Non-Opioid Treatment for Chronic Post-Amputation Pain
Devices Neurology FDA
 HSMN NewsFeed - 23 Jul 2025
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas(TM) Wearable Injector Technology for Biologic Drugs
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 22 Jul 2025
SPRITAM(R) (levetiracetam) Tablets for Oral Suspension Approved by FDA for Nasogastric and Gastrostomy Tube Administration
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 Jul 2025
Centinel Spine(R) prodisc(R) Total Disc Replacement Grows 47% Worldwide in Second Quarter 2025, Setting New Revenue Record
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 18 Jul 2025
B. Braun Expands Heparin Sodium Injection Portfolio to Seven Heparin Premixed Sodium Injection Products
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 17 Jul 2025
Saluda Medical Announces Full U.S. Launch of EVA(TM) Sensing Technology for Use with the Evoke(R) SmartLoop(TM) System
Devices Neurology Product Launch
 HSMN NewsFeed - 17 Jul 2025
Xeltis Announces Positive Data for Xabg, its Coronary Artery Bypass Conduit, in EU Clinical Trial
Devices Surgery Cardiology
 HSMN NewsFeed - 16 Jul 2025
Piccolo Medical, Inc. Receives FDA Clearance for 2nd Generation SmartPICC(R) Technology
Devices FDA
 HSMN NewsFeed - 15 Jul 2025
Tract Bio Appoints Chris Galloway, M.D., as Chief Medical and Development Officer and Expands Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2025
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 14 Jul 2025
Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 11 Jul 2025
Tomoverse Imaging Inc. Announces Closing of $5 Million Dollar Seed Funding Round Led by Strategic Canadian Family Office
Devices Radiology Cardiology Venture Capital
 HSMN NewsFeed - 10 Jul 2025
Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 9 Jul 2025
Neuros Medical Secures $56M Series D to Commercialize the Altius(R) System, an FDA-Approved, Non-Opioid Nerve Stimulation System for Chronic Post-Amputation Pain
Devices Venture Capital
 HSMN NewsFeed - 8 Jul 2025
Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jul 2025
Boston Scientific Receives FDA Approval for Expanded Labeling of FARAPULSE(TM) Pulsed Field Ablation System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 3 Jul 2025
Novartis Provides Update on Phase III GCAptAIN Study of Cosentyx(R) in Giant Cell Arteritis (GCA)
Biopharmaceuticals
 HSMN NewsFeed - 2 Jul 2025
Moon Surgical Receives FDA Clearance for Maestro(TM) Connectivity and Predetermined Change Control Plan for AI-Powered ScoPilot(R)
Devices Surgery FDA
 HSMN NewsFeed - 30 Jun 2025
NewLines(TM) App Update Extends AI-Assisted SmartProfiles(TM) to the Android Platform
Devices Biopharmaceuticals Diagnostics Distribution
 HSMN NewsFeed - 30 Jun 2025
Oncolytics Biotech(R) Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Jun 2025
RaySearch Releases RayCare v2025
Devices Oncology Product Launch
 HSMN NewsFeed - 25 Jun 2025
Viking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program with GLP-1/GIP Agonist VK2735
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 24 Jun 2025
Ascidian Therapeutics Appoints Dr. Murray A. Abramson as Chief Development Officer and Establishes Ophthalmology Clinical Advisory Board to Advance ACDN-01 for Treatment of Stargardt Disease
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 23 Jun 2025
Sephience(TM) (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Jun 2025
Lomond Therapeutics Announces U.S. FDA Clearance of IND Application for Lonitoclax, a Selective BCL2 Inhibitor with Limited Immune Suppression and Improved Safety Compared to Venetoclax and Venetoclax- Like Molecules
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Jun 2025
Johnson & Johnson Launches VOLT(TM) Wrist and Proximal Humerus Plating Systems in the U.S.
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 18 Jun 2025
Neurvati Neurosciences and GRIN Therapeutics Announce Appointment of Gail Farfel, PhD to Their Boards of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Jun 2025
Solu Therapeutics Appoints Enda Moran, PhD, MBA as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Jun 2025
RayStation Used for Pioneering Clinical Milestone at Helsinki University Hospital - First Treatment with Accelerator-Based BNCT in Europe
Devices Oncology
 HSMN NewsFeed - 13 Jun 2025
U.S. Food & Drug Administration (FDA) Approves Investigational New Drug (IND) Application for Myrio's Lead Product (PHOX2B PC-CAR T) for the Treatment of Neuroblastoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Jun 2025
Medtronic Announces MiniMed as Name for Planned New Diabetes Company
Devices Endocrinology Mergers & Acquisitions
 HSMN NewsFeed - 12 Jun 2025
MolecuLight(R) Imaging Significantly Improves Outcomes and Cuts Costs for Deep Sternal Wound Infections in Taiwan Study; Signals Expansion into Surgical Applications
Devices Wound Care
 HSMN NewsFeed - 11 Jun 2025
SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
Regenerative Medicine Ophthalmology Venture Capital
 HSMN NewsFeed - 10 Jun 2025
Cristcot Appoints Richard Kim as Chief Commercial Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 9 Jun 2025
TYBR Health Announces FDA 510(k) Clearance for B3 GEL(TM) System, a Flowable Bio-Gel to Protect Healing Tissue and Preserve Function
Devices Regenerative Medicine Surgery FDA
 HSMN NewsFeed - 6 Jun 2025
Hemispherian Receives Positive Opinion for Orphan Medicinal Product Designation in the EU for GLIX1 in Glioma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Jun 2025
Penumbra Introduces the Ruby(R) XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization
Devices Interventional FDA Product Launch
 HSMN NewsFeed - 5 Jun 2025
Spineart Announces Full-Market Launch of SCARLET(R) AC-Ti Secured Anterior Cervical Cage in the US
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 4 Jun 2025
Cardinal Health Launches New Medical Device for the Continuous Monitoring of Three Essential Vital Signs in One System
Devices Monitoring Product Launch
 HSMN NewsFeed - 2 Jun 2025
Sanofi to Acquire Blueprint Medicines, Expanding Portfolio in Rare Immunological Disease and Adding Early-stage Pipeline in Immunology
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 May 2025
Isotopia and Cardirad Announce Launch of Isoprotrace(R) in Sweden and Denmark, Expanding Access to Advanced Prostate Cancer Imaging
Biopharmaceuticals Radiology Oncology Product Launch
 HSMN NewsFeed - 29 May 2025
First in human use of Remanufactured da Vinci Xi(R) Robotic Instruments
Devices Surgery
 HSMN NewsFeed - 28 May 2025
BD to Initiate Real-World Patient Data Registry for the Rotarex(TM) Atherectomy System in Treatment of Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 27 May 2025
BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn(R) Phase 3b ALS Clinical Trials
Regenerative Medicine Neurology
 HSMN NewsFeed - 23 May 2025
England's NICE Recommends FILSPARI(R) (sparsentan) as a Treatment Option for IgA Nephropathy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 May 2025
ulrich medical USA(R) Appoints Eric Gibbs as President and General Manager
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 21 May 2025
Medtronic Announces Intent to Separate Diabetes Business
Devices Endocrinology Drug Delivery
 HSMN NewsFeed - 20 May 2025
Baxter Launches HEMOPATCH Sealing Hemostat, a Room-Temperature Collagen Pad Approved for Hemostasis and Sealing, Suitable for Open Surgery and Minimally Invasive Surgical Procedures (MIS)
Devices Surgery Product Launch
 HSMN NewsFeed - 20 May 2025
Ritedose Pharmaceuticals Receives FDA Approval for Albuterol Sulfate Inhalation Solution, 0.5% (2.5 mg/0.5 mL)*--Addressing Nationwide Shortage of the Essential Drug
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 May 2025
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn(R) for ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 19 May 2025
Trax Surgical Receives FDA 510(k) Clearance for Nitinol Staple System
Devices Orthopaedic FDA
 HSMN NewsFeed - 16 May 2025
BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 May 2025
Neutron Therapeutics and Helsinki University Hospital Treat First Head and Neck Cancer Patients Using Accelerator-Based Boron Neutron Capture Therapy
Devices Oncology
 HSMN NewsFeed - 15 May 2025
Alpheus Medical Raises $52M in Series B Round to Advance Groundbreaking Glioblastoma Therapy
Devices Oncology Venture Capital
 HSMN NewsFeed - 12 May 2025
Ted Myles Joins Cellarity as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2025
FDA Approves Teal Health's Teal Wand(TM)--The First and Only At-Home Self-Collection Device for Cervical Cancer Screening, Introducing a Comfortable Alternative to In-Person Screening
Devices Diagnostics FDA
 HSMN NewsFeed - 8 May 2025
Lilly Announces Transitions in Executive Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 May 2025
Sumitomo Corporation Acquires Full Ownership of U.S.-based ActivStyle, Provider of Home Medical Supplies for Patients with Chronic Conditions
Devices Mergers & Acquisitions
 HSMN NewsFeed - 6 May 2025
Leo Cancer Care Particle Therapy Solution Marie is Now 510(k) Pending
Devices Oncology FDA
 HSMN NewsFeed - 5 May 2025
Spinogenix Announces FDA-Authorized Expanded Access Program for SPG302, the First Synaptic Regenerative Therapy to Treat ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 2 May 2025
RaySearch releases RayStation v2025
Devices Oncology Product Launch
 HSMN NewsFeed - 30 Apr 2025
Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Apr 2025
Lutris Pharma Announces the Appointment of Seasoned Life Science Executive, Sumant Ramachandra, M.D., Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2025
IceCure Exhibits ProSense(R) & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium
Devices Oncology
 HSMN NewsFeed - 25 Apr 2025
FDA Clears New Clarius Prostate AI To Help Physicians Assess and Diagnose Common Urologic Conditions in Minutes
Devices Urology FDA
 HSMN NewsFeed - 24 Apr 2025
Medtronic Advances Abbott CGM Partnership with FDA Submission of Interoperable Insulin Pump
Devices Endocrinology FDA
 HSMN NewsFeed - 23 Apr 2025
Boston Scientific Chief Financial Officer (CFO) Dan Brennan to Retire; Jon Monson, Senior Vice President, Investor Relations to Succeed Brennan
Devices Personnel
 HSMN NewsFeed - 22 Apr 2025
LifeSignals launches UbiqVue(TM) Holter System in partnership with UltraLinQ at Heart Rhythm 2025
Devices Monitoring Cardiology Product Launch
 HSMN NewsFeed - 21 Apr 2025
BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support
Devices Monitoring Product Launch
 HSMN NewsFeed - 18 Apr 2025
Leidos Invests $10 Million in AI Disease Detection with University of Pittsburgh
Diagnostics
 HSMN NewsFeed - 17 Apr 2025
MAP Medical Launches as Innovative Medical Supply Concierge
Devices Distribution Product Launch
 HSMN NewsFeed - 16 Apr 2025
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
Devices Orthopaedic Wound Care Venture Capital
 HSMN NewsFeed - 14 Apr 2025
CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America
Devices Personnel
 HSMN NewsFeed - 14 Apr 2025
Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 11 Apr 2025
Turbett Surgical Receives FDA 510(k) Clearance for Enhanced Instrument Pod Portfolio
Devices Surgery FDA
 HSMN NewsFeed - 10 Apr 2025
BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 9 Apr 2025
Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML and Other Advanced Hematologic Malignancies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 8 Apr 2025
Brainomix Advances Stroke Care with Landmark FDA Clearance
Devices Neurology FDA
 HSMN NewsFeed - 4 Apr 2025
Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 2 Apr 2025
Append Medical Appoints Shlomi Nachman as Chairman of the Board
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 1 Apr 2025
Zimmer Biomet Receives CE Mark Approval for RibFix Advantage(R) Fixation System
Devices Regulatory Orthopaedic
 HSMN NewsFeed - 31 Mar 2025
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 31 Mar 2025
Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Mar 2025
Photocure Appoints Jane Healy as Vice President and General Manager EMEA
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Mar 2025
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 24 Mar 2025
Newronika Receives CE Mark Approval for AlphaDBS, Advancing Adaptive Deep Brain Stimulation for Parkinson's Disease
Devices Neurology Regulatory
 HSMN NewsFeed - 21 Mar 2025
Accuryn Medical Announces Leadership Transition With Appointment of Todd Dunn as CEO
Devices Monitoring Personnel
 HSMN NewsFeed - 19 Mar 2025
Terumo Neuro Celebrates 15 Years of the WEB(TM) Device: A Game-Changing Innovation in Aneurysm Treatment
Devices Interventional Neurology
 HSMN NewsFeed - 18 Mar 2025
Artisight Expands Collaborations with NVIDIA and KARL STORZ to Transform Operating Room Technology Through AI and Automation
Devices Surgery
 HSMN NewsFeed - 17 Mar 2025
Surf Bio Appoints Industry Veteran Doug Hecker as Head of Technical Operations
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 13 Mar 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 10 Mar 2025
Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 7 Mar 2025
Zimmer Biomet Receives FDA Clearance for Persona(R) Revision SoluTion(TM) Femur
Devices Orthopaedic FDA
 HSMN NewsFeed - 6 Mar 2025
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 5 Mar 2025
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 4 Mar 2025
The Chinese Carbon Ion Center Heyou Hospital Selects RayStation
Devices Oncology
 HSMN NewsFeed - 4 Mar 2025
Nervonik Raises $13 Million in Series A Financing to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Relief
Devices Neurology Venture Capital
 HSMN NewsFeed - 3 Mar 2025
Boston Scientific Announces Agreement to Acquire SoniVie Ltd.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 28 Feb 2025
RFA For Life Announces New American Medical Association CPT(R) Codes for Thyroid Nodule Radiofrequency Ablation (RFA)
Devices Oncology Reimbursement
 HSMN NewsFeed - 27 Feb 2025
Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 27 Feb 2025
Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2025
ABANZA Receives FDA 510(k) Clearance for WasherCap(TM) Mini Implantable Fixation Device
Devices Orthopaedic FDA
 HSMN NewsFeed - 25 Feb 2025
Alpheus Medical Publishes Promising Early Clinical Results of Sonodynamic Therapy for the Treatment of Newly Diagnosed Glioblastomas
Devices Neurosurgery Oncology
 HSMN NewsFeed - 24 Feb 2025
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense(TM) Cryoablation System in Israel
Devices Oncology Regulatory
 HSMN NewsFeed - 21 Feb 2025
FDA Declares Wegovy(R) and Ozempic(R) Shortage is Over and that Novo Nordisk is Fully Meeting or Exceeding Nationwide Demand for All Doses
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Feb 2025
Biosion, Inc. Appoints Kedan Lin, Ph.D., as Chief Development Officer and President of Biosion US
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Feb 2025
Oncolytics Biotech(R) Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Feb 2025
Stryker Launches ProCeed Hospital Bed
Devices Product Launch
 HSMN NewsFeed - 14 Feb 2025
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2025
Roche Elecsys sFlt-1/PlGF Ratio for Preeclampsia Receives FDA 510(k) Clearance, Offering a Fast and Raliable Way to Predict the Risk of Developing Severe Preeclampsia
Diagnostics FDA
 HSMN NewsFeed - 12 Feb 2025
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 10 Feb 2025
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 7 Feb 2025
Most Patients on Lilly's Omvoh(R) (mirikizumab-mrkz) for Crohn's Disease Achieved Sustained Clinical Remission and Endoscopic Response at Two Years
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 6 Feb 2025
Accuryn Medical Welcomes Business Innovation Leader to Support Team in Transforming Kidney Care
Devices Monitoring Personnel
 HSMN NewsFeed - 4 Feb 2025
MedRhythms Hires Joel Behnke as Chief Commercial Officer; Announces New Publications in Support of InTandem(R)
Devices Neurology Personnel
 HSMN NewsFeed - 3 Feb 2025
CHMP Issues Positive Opinion for Subcutaneous RYBREVANT(R)(amivantamab) Co-Formulated with ENHANZE(R) for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 31 Jan 2025
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Jan 2025
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jan 2025
Aspen Medical Products Acquires Advanced Orthopaedics
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 27 Jan 2025
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2025
Nuevocor Welcomes Andreas Wallnöfer as Chairman of the Board of Directors
Regenerative Medicine Cardiology Personnel
 HSMN NewsFeed - 23 Jan 2025
Vantis Vascular Announces Superior Clinical Performance of the Crossfast Advanced Delivery System in First Commercial Cases
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 22 Jan 2025
Shotel(TM) Medical Expansion Signals Growing Demand for Its Ankle Arthrodesis Device
Devices Orthopaedic Distribution
 HSMN NewsFeed - 21 Jan 2025
Medtronic appoints Thierry Piéton as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 17 Jan 2025
FDA Approves LUMAKRAS(R) (Sotorasib) in Combination with Vectibix(R) (Panitumumab) for Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Jan 2025
UCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX(R) (bimekizumab-bkzx)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 15 Jan 2025
New Drug Application Initiated with U.S. FDA for TAR-200, the First and Only Intravesical Drug Releasing System for Patients with BCG-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 14 Jan 2025
LUMA Vision Successfully Completes First-in-Human Procedures with its Novel VERAFEYE(TM) Navigation and Visualization Platform
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Jan 2025
Cresilon Announces U.S. Nationwide Launch of TRAUMAGEL
Devices FDA
 HSMN NewsFeed - 13 Jan 2025
Medtronic Achieves CE Mark Approval for BrainSense Adaptive Deep Brain Stimulation and Electrode Identifier, a Groundbreaking Advance In Personalized, Sensing-Enabled Care for People with Parkinson's Through Innovative Brain-Computer Interface Technology
Devices Neurosurgery Regulatory
 HSMN NewsFeed - 13 Jan 2025
Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
Diagnostics Oncology FDA
 HSMN NewsFeed - 10 Jan 2025
Mediar Therapeutics Enters into Global Licensing Agreement with Lilly to Advance First-in-Class WISP1 Antibody for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Jan 2025
Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Jan 2025
FindReps(R) App Update Features AI-Assisted SmartProfiles(TM)
Devices Biopharmaceuticals Diagnostics Distribution
 HSMN NewsFeed - 7 Jan 2025
Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment
Devices Interventional
 HSMN NewsFeed - 6 Jan 2025
Ocutrx Debuts DigiLoupes(TM) Headset with Advanced AR/XR and Pancake Lens Technology for the First Time in the U.S.
Devices Surgery Product Launch
 HSMN NewsFeed - 3 Jan 2025
The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot
Devices Dermatology
 HSMN NewsFeed - 2 Jan 2025
Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors
Devices Monitoring Personnel
 HSMN NewsFeed - 31 Dec 2024
Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Dec 2024
Halozyme Announces FDA Approval of Bristol Myers Squibb's Opdivo Qvantig(TM) with ENHANZE(R) for Subcutaneous Use in Most Previously Approved Adult Solid Tumor Opdivo(R) (nivolumab) Indications
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 26 Dec 2024
Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Dec 2024
Stuart Therapeutics Announces the Appointment of Two New Board Members
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 23 Dec 2024
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
Biopharmaceuticals
 HSMN NewsFeed - 20 Dec 2024
Neurocrine Biosciences Announces Commercial Availability of CRENESSITY(TM) (crinecerfont) for Children and Adults With Classic Congenital Adrenal Hyperplasia
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 19 Dec 2024
Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 18 Dec 2024
New Data Indicates the CyberKnife(R) System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat
Devices Oncology Neurosurgery
 HSMN NewsFeed - 17 Dec 2024
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
Diagnostics Product Launch
 HSMN NewsFeed - 16 Dec 2024
Tackling the ACL Tear Epidemic in Youth Athletes: A Promising Solution from Arthrex
Devices Orthopaedic
 HSMN NewsFeed - 13 Dec 2024
Zimmer Biomet Receives FDA Clearance for OsseoFit(TM) Stemless Shoulder System for Total Shoulder Replacement
Devices Orthopaedic FDA
 HSMN NewsFeed - 12 Dec 2024
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
Devices Cardiology FDA
 HSMN NewsFeed - 11 Dec 2024
Ariceum Therapeutics and NorthStar Medical Radioisotopes Announce Supply Agreement for Therapeutic Radioisotope Actinium-225
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Dec 2024
PENTAX Medical Obtained US FDA 510(k) Clearance for New Models of the PENTAX Medical i20c Video Endoscope Series
Devices Gastroenterology FDA
 HSMN NewsFeed - 9 Dec 2024
AnX Robotica awarded Gastrointestinal Endoscopy Products agreement with Premier, Inc.
Devices Gastroenterology Group Purchasing
 HSMN NewsFeed - 6 Dec 2024
EQT Life Sciences Leads Series A Funding Round for Maternal Health Company Nua Surgical
Devices Surgery Venture Capital
 HSMN NewsFeed - 5 Dec 2024
Sapience Therapeutics Strengthens Board of Directors and Management Team with Esteemed Business Development Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2024
Study published in the New England Journal of Medicine AI Concludes that the Sepsis ImmunoScore(TM), the First FDA-Authorized AI Tool for Sepsis, has both significant Diagnostic and Predictive Power
Diagnostics
 HSMN NewsFeed - 3 Dec 2024
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
Devices Interventional Product Launch
 HSMN NewsFeed - 2 Dec 2024
Mallinckrodt Completes Divestiture of Therakos(R) Business
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 27 Nov 2024
PTC Therapeutics Enters into Agreement to Sell Priority Review Voucher for $150 Million
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Nov 2024
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Nov 2024
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE(TM) Cord Blood Cell Therapy Product
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Nov 2024
Bioretec Signed a New Sales and Distribution Agreement to Accelerate the Commercialization of RemeOs(TM) Trauma Screw in the U.S. Civilian Hospital Market
Devices Orthopaedic Distribution
 HSMN NewsFeed - 21 Nov 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
Diagnostics Product Launch
 HSMN NewsFeed - 20 Nov 2024
Medtronic Receives FDA Clearance for New InPen(TM) App, Paving the Way for its Smart MDI System Launch with Simplera(TM) CGM
Devices Monitoring FDA
 HSMN NewsFeed - 19 Nov 2024
THINK Surgical Receives FDA 510(k) Clearance to Use Freedom(R) Total Knee, Freedom Titan(R) Knee, and Freedom Primary PCK(R) System Implants with TMINI(R) Miniature Robotic System
Devices Orthopaedic FDA
 HSMN NewsFeed - 18 Nov 2024
Zimmer Biomet Announces CE Mark Certification for Persona(R) Revision Knee System
Devices Orthopaedic Regulatory
 HSMN NewsFeed - 18 Nov 2024
IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Nov 2024
Boston Scientific Closes Acquisition of Axonics, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 14 Nov 2024
Stryker Launches Next Generation of SurgiCount+ to Help Improve the Standard of Care in Hospitals for Sponge Management and Blood Loss Assessment
Devices Surgery Product Launch
 HSMN NewsFeed - 13 Nov 2024
Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 13 Nov 2024
SmartCardia Receives FDA Clearance for Outpatient Cardiac Telemetry for Its 7-Lead ECG Patch and Cloud Platform
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 12 Nov 2024
Nevro's HFX iQ(TM) Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally
Devices Regulatory
 HSMN NewsFeed - 8 Nov 2024
FDA Advisory Panel Votes in Favor of IceCure's ProSense(R) Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer
Devices Oncology FDA
 HSMN NewsFeed - 7 Nov 2024
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2024
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Nov 2024
Xeltis expands leadership team with appointment of Luc Verhees as Vice President of Clinical Business Development
Devices Personnel
 HSMN NewsFeed - 4 Nov 2024
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 1 Nov 2024
CARsgen(R) U.S. Clinical Holds Lifted by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Oct 2024
Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO(R) in South Korea
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 30 Oct 2024
Laura J. Seplavy, MS, Joins Perosphere as Executive Vice President, Marketing and External Relations
Devices Diagnostics Personnel
 HSMN NewsFeed - 30 Oct 2024
FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Oct 2024
Protega Pharmaceuticals Receives FDA Approval for ROXYBOND(TM) (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Oct 2024
Zimmer Biomet to Debut New Z1(TM) Femoral Hip System and Clinical Data on G7(R) Acetabular System at 2024 AAHKS Annual Meeting
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 25 Oct 2024
Lilly's EBGLYSS(TM) (lebrikizumab-lbkz) Demonstrated Meaningful Improvement in Skin Clearance and Itch Relief in the Majority of Patients with Moderate-To-Severe Atopic Dermatitis Who Discontinued Dupilumab
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 24 Oct 2024
Pillar Biosciences Receives CPT(R) Code for FDA Approved oncoReveal(TM) CDx Pan-Cancer Solid tumor IVD Kit
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 24 Oct 2024
Accent Therapeutics Announces FDA Clearance of IND Application for ATX-559, a First-In-Class Oral DHX9 Inhibitor
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Oct 2024
AvenCell Raises $112 Million in Series B; Funding Led by Novo Holdings
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Oct 2024
CHMP Maintains Negative Opinion on Translarna(TM) Reexamination
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Oct 2024
MolecuLight's Fluorescence Imaging: A Game-Changer for Bedside Biofilm Detection
Devices Wound Care
 HSMN NewsFeed - 16 Oct 2024
Bracco Diagnostics Inc. and Subtle Medical Announce FDA Clearance of AiMIFY(TM) Software for Enhanced MRI
Devices Radiology FDA
 HSMN NewsFeed - 15 Oct 2024
Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne
Devices Dermatology FDA
 HSMN NewsFeed - 14 Oct 2024
Mari Hoidal joins Avails Medical as Vice President of Marketing
Diagnostics Personnel
 HSMN NewsFeed - 11 Oct 2024
X-Bolt Announces First U.S. Implant of Pro-X1(R) Trochanteric Nailing System
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 10 Oct 2024
Rivermark Medical Closes $30 Million Series C Financing to Advance Development of Flostent(TM) System for Benign Prostatic Hyperplasia
Devices Urology Venture Capital
 HSMN NewsFeed - 10 Oct 2024
Johnson & Johnson MedTech Launches VOLT(TM) Plating System
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 9 Oct 2024
ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine
Devices Neurology Venture Capital
 HSMN NewsFeed - 9 Oct 2024
Inspira(TM) Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism
Devices
 HSMN NewsFeed - 8 Oct 2024
Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee(TM), a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care
Devices Orthopaedic FDA
 HSMN NewsFeed - 8 Oct 2024
BTL's Emsculpt Neo Secures FDA Clearance for Treating Medical Diseases and Conditions, Expanding Market Reach
Devices FDA
 HSMN NewsFeed - 7 Oct 2024
ALK Announces U.S. FDA Approval of New AccuTest(TM) Allergy Skin Testing Devices for Optimized Allergy Testing and Diagnosis
Diagnostics FDA
 HSMN NewsFeed - 4 Oct 2024
Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life
Devices Drug Delivery Product Recall
 HSMN NewsFeed - 3 Oct 2024
Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Oct 2024
Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo(R) in the US
Biopharmaceuticals Distribution
 HSMN NewsFeed - 1 Oct 2024
Auto Depth Digital Wound Measurement Now Available on MolecuLightDX
Devices Wound Care Product Launch
 HSMN NewsFeed - 30 Sep 2024
Aktis Oncology Announces $175 Million Oversubscribed Series B Financing to Further Advance its Proprietary Radiopharmaceutical Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Sep 2024
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE(TM) Pulsed Field Ablation System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 26 Sep 2024
FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Sep 2024
Medtronic Expands AiBLE(TM) Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership
Devices Neurosurgery Surgery Product Launch
 HSMN NewsFeed - 25 Sep 2024
Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF(R) Vial Access Needle ("VAN")
Devices Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 24 Sep 2024
B. Braun Medical Receives FDA Clearance for Introcan Safety(R) 2 Deep Access IV Catheter
Devices FDA
 HSMN NewsFeed - 23 Sep 2024
UCB Announces U.S. FDA Approvals for BIMZELX(R) (bimekizumab-bkzx) for the Treatment of Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Sep 2024
FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Sep 2024
Accord BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of 420mg Strength of HERCESSI(TM) (trastuzumab-strf), a biosimilar to Herceptin(R) (trastuzumab), for the Treatment of Several Forms of HER2-Overexpressing Cancer
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 17 Sep 2024
Boston Scientific Receives FDA Approval for Expanded Indication of INGEVITY(TM)+ Pacing Leads to Include Conduction System Pacing of the Left Bundle Branch Area
Devices Cardiology FDA
 HSMN NewsFeed - 16 Sep 2024
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash(TM) 2.0 and Lightning Bolt(TM) 7 - in Europe
Devices Interventional Regulatory
 HSMN NewsFeed - 13 Sep 2024
Alume Biosciences Appoints Rick Gonzalez as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2024
Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis
Diagnostics Venture Capital
 HSMN NewsFeed - 11 Sep 2024
Breg, Inc. Announces Organizational Leadership Changes
Devices Personnel
 HSMN NewsFeed - 10 Sep 2024
Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.(R) Therapy
Devices Wound Care Product Launch
 HSMN NewsFeed - 9 Sep 2024
Lilly appoints Lucas Montarce as executive vice president and chief financial officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2024
Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations
Devices Orthopaedic Personnel
 HSMN NewsFeed - 4 Sep 2024
Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral occlusions
Devices Interventional Product Launch
 HSMN NewsFeed - 30 Aug 2024
Sanyou Bio Launches Comprehensive Monkeypox Product Line
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 28 Aug 2024
Neuros Medical Receives FDA Approval for the Altius(R) Direct Electrical Nerve Stimulation System
Devices FDA
 HSMN NewsFeed - 27 Aug 2024
Endo Announces CEO Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2024
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 21 Aug 2024
PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 21 Aug 2024
Connecticut Proton Therapy Center selects RayCare
Devices Oncology
 HSMN NewsFeed - 20 Aug 2024
Pathalys Pharma Secures $105 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Aug 2024
RYBREVANT(R) (amivantamab-vmjw) Plus LAZCLUZE(TM) (lazertinib) Approved in the U.S. as a First-line Chemotherapy-free Treatment for Patients with EGFR-mutated Advanced Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Aug 2024
Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 16 Aug 2024
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Aug 2024
Haemonetics Announces Full Market Release for VASCADE MVP(R) XL Vascular Closure System
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 14 Aug 2024
IceCure's ProSense(R) Destroyed 100% of Breast Cancer Tumors in Independent Study of Patients Who Chose Cryoablation Instead of Surgery
Devices Oncology
 HSMN NewsFeed - 13 Aug 2024
Surgical Planning Associates Receives FDA Clearance for New HipInsight System(R) 2.0 Mixed-Reality System for Hip Arthroplasty
Devices Orthopaedic FDA
 HSMN NewsFeed - 12 Aug 2024
BD Names Michael Feld as President of Life Sciences Segment
Diagnostics Personnel
 HSMN NewsFeed - 9 Aug 2024
FDA Approves First Nasal Spray for Treatment of Anaphylaxis
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 8 Aug 2024
Sobi and Apellis announce positive topline results from phase 3 VALIANT study of pegcetacoplan in C3G and primary IC-MPGN
Biopharmaceuticals
 HSMN NewsFeed - 6 Aug 2024
NeuroTherapia Raises $12.3M in the First Close of its Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 5 Aug 2024
Mallinckrodt Reaches Agreement to Sell Therakos(R) Business to CVC for $925 Million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 5 Aug 2024
Dignify Therapeutics welcomes leading spinal injury expert Alexander "Sasha" Rabchevsky PhD, to its Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2024
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase(R) Laser
Devices Ophthalmology Regulatory Distribution
 HSMN NewsFeed - 29 Jul 2024
Syndax Announces PDUFA Action Date Extension for Revumenib NDA for Relapsed or Refractory KMT2Ar Acute Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Jul 2024
ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 25 Jul 2024
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
Diagnostics Oncology
 HSMN NewsFeed - 24 Jul 2024
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment
Biopharmaceuticals Drug Delivery Neurology
 HSMN NewsFeed - 23 Jul 2024
Magenta Medical Closes $105M Financing Led by Novo Holdings
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 22 Jul 2024
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2024
Rona Therapeutics Raises $35 Million Series A+ Financing to Advance Innovative Metabolic siRNA Pipeline in Clinic and Next Generation RNA Platforms
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jul 2024
Tufts Medical Center Becomes First Hospital in Massachusetts to Adopt MOLLI Surgical's Breast Cancer Technology
Devices Surgery
 HSMN NewsFeed - 17 Jul 2024
Alltrna Announces Updates to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2024
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jul 2024
Bedal International raises $11 Million to boost growth of its FlexGRIP(R) catheter securement devices
Devices Venture Capital
 HSMN NewsFeed - 11 Jul 2024
Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo(R) (vadadustat) Tablets
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2024
AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2024
Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer
Devices Diagnostics Product Launch
 HSMN NewsFeed - 8 Jul 2024
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 5 Jul 2024
Biostar Pharma Announces FDA Clearance of the IND Application for a Phase 2 Study of Utidelone Injection (UTD1) in HER2- Breast Cancer Brain Metastasis
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Jul 2024
Alafair Biosciences Awarded Synthetic Implantable Products Agreement with Premier, Inc. for VersaWrap(R) Hydrogel Sheet
Devices Surgery Group Purchasing
 HSMN NewsFeed - 1 Jul 2024
RaySearch releases RayStation 2024B
Devices Oncology Product Launch
 HSMN NewsFeed - 28 Jun 2024
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY(R)) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 Jun 2024
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
Devices Venture Capital
 HSMN NewsFeed - 26 Jun 2024
BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn(R) Clinical Trial
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 25 Jun 2024
Halozyme Announces Roche's OCREVUS(R) SC with ENHANZE(R) Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 24 Jun 2024
Harmony Biosciences Receives U.S. Food And Drug Administration Approval For Wakix(R) (Pitolisant) In Pediatric Patients With Narcolepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Jun 2024
FDA Authorizes Marketing of Four Menthol-Flavored E-Cigarette Products After Extensive Scientific Review
Drug Delivery FDA
 HSMN NewsFeed - 20 Jun 2024
BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 19 Jun 2024
European Commission grants Sobi(R) Marketing Authorisation for ALTUVOCT(TM) for treatment of haemophilia A
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Jun 2024
Roche receives FDA clearance on its digital pathology solution for diagnostic use
Devices Diagnostics FDA
 HSMN NewsFeed - 17 Jun 2024
Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in ALS Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Jun 2024
TALVEY(R) (talquetamab-tgvs) Demonstrates Highly Durable, Longer-Term Responses in Patients with Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Jun 2024
Xeltis receives IDE approval from FDA for initiation of US pivotal trial for aXess(TM), its restorative vascular access conduit
Devices FDA
 HSMN NewsFeed - 12 Jun 2024
REGENXBIO Announces Leadership Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2024
Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI(R) Miniature Handheld Robotic System for Total Knee Arthroplasty
Devices Surgery Distribution
 HSMN NewsFeed - 10 Jun 2024
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 7 Jun 2024
DePuy Synthes Receives 510(k) FDA Clearance of the VELYS(TM) Robotic-Assisted Solution for Use in Unicompartmental Knee Arthroplasty Procedures
Devices Orthopaedic FDA
 HSMN NewsFeed - 6 Jun 2024
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Jun 2024
Moon Surgical receives second FDA clearance, covering its commercial Maestro(TM) Robotic Surgery System
Devices Surgery FDA
 HSMN NewsFeed - 5 Jun 2024
Lilly announces departure of Anat Ashkenazi, chief financial officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2024
Zeto obtains FDA 510(k) clearance for its groundbreaking next-generation EEG brain monitoring product, ONE.
Devices Neurology Monitoring FDA
 HSMN NewsFeed - 3 Jun 2024
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
Devices Monitoring Acquisitions
 HSMN NewsFeed - 31 May 2024
SIFI Receives Positive CHMP Opinion for Akantior(R) (polihexanide 0.08%) in Acanthamoeba Keratitis
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 30 May 2024
McDavid Launches NRG Knee Brace Line with Joint Assistance Hinge System
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 29 May 2024
Beckman Coulter Secures FDA Clearance for Heart Failure Assay on DxI 9000 Immunoassay Analyzer
Devices Diagnostics Cardiology FDA
 HSMN NewsFeed - 28 May 2024
IDEAYA Biosciences Appoints Daniel A. Simon as Chief Business Officer to Lead Corporate Strategy and Business Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 May 2024
Roche And Hitachi High-Tech Extend their 46-Year Partnership, Paving the Way for Further Breakthroughs in Diagnostic Testing
Diagnostics
 HSMN NewsFeed - 24 May 2024
YS Biopharma Announces Name Change to LakeShore Biopharma
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2024
Virtual-Ports Receives CE Certification for Revolutionary Surgical Products
Devices Surgery Regulatory
 HSMN NewsFeed - 21 May 2024
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili(TM). Enters U.S. Ophthalmology Market
Biopharmaceuticals Generics Ophthalmology FDA
 HSMN NewsFeed - 20 May 2024
Shoulder Innovations Launches InSet(TM) 95 Humeral Stem
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 15 May 2024
Compugen Appoints David Silberman as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 May 2024
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 May 2024
CereVasc Announces $70 Million Series B Financing to Advance its Novel eShunt(R) System for the Treatment of Normal Pressure Hydrocephalus
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 13 May 2024
Laborie Unveils Positive Study Results for Optilume(R) BPH Catheter System
Devices Urology
 HSMN NewsFeed - 9 May 2024
OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN)
Devices Orthopaedic FDA
 HSMN NewsFeed - 8 May 2024
4C Medical's AltaValve System Secures Dual FDA Breakthrough Device Designations, Expediting Patient Access to Advanced Mitral Valve Therapies
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 7 May 2024
Rad AI Closes $50 Million to Empower Physicians with AI
Devices Radiology Venture Capital
 HSMN NewsFeed - 6 May 2024
Scientia Vascular Announces FDA approvals for New Line of Microfabricated Neurovascular Catheters
Devices Interventional Neurology FDA
 HSMN NewsFeed - 3 May 2024
Leading Academic Neurosurgeons Describe New NICO Myriad SPECTRA(TM) System as a 'Game-Changing Advancement' in Surgical Removal of High-Grade Glioma Brain Tumors
Devices Neurosurgery Oncology
 HSMN NewsFeed - 2 May 2024
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 May 2024
PreludeDx Welcomes Dr. Pat Whitworth as Chief Medical Officer to Drive Expansion of Precision Diagnostics
Diagnostics Oncology Personnel
 HSMN NewsFeed - 30 Apr 2024
Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2024
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Biopharmaceuticals Diagnostics FDA
 HSMN NewsFeed - 29 Apr 2024
Repertoire(R) Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
Biopharmaceuticals
 HSMN NewsFeed - 26 Apr 2024
Sobi(R) Receives Positive CHMP Opinion Recommending Approval of Efanesoctocog Alfa for Once-Weekly Treatment of Haemophilia A
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Apr 2024
Provisio Medical Announces FDA Clearance of the Provisio SLT IVUS(TM) System
Devices FDA
 HSMN NewsFeed - 24 Apr 2024
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 19 Apr 2024
Legacy Medical Consultants Announces Reeva FT(TM), a Full-Thickness Allograft for Wound Covering and Protection During Treatment
Devices Wound Care Product Launch Reimbursement
 HSMN NewsFeed - 18 Apr 2024
Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Apr 2024
Sensorium Therapeutics Appoints Sam Rasty as Chief Business Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Apr 2024
Xstim, Inc. Receives FDA Approval for Xstim(TM) Spine Fusion Stimulator
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 15 Apr 2024
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Diagnostics Neurology Product Launch
 HSMN NewsFeed - 15 Apr 2024
Hyalex Orthopaedics Appoints Thomas Vail, M.D., as Chief Medical Officer and Names Adam Gridley to Board of Directors
Devices Orthopaedic Personnel
 HSMN NewsFeed - 12 Apr 2024
Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data
Devices Cardiology Interventional
 HSMN NewsFeed - 11 Apr 2024
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2024
TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Apr 2024
NeuroCatch Introduces PeakSelect, Enabling a Deeper Clinical Dive into Brain Vital Signs at a Doctor's Office Near You
Devices Neurology Product Launch
 HSMN NewsFeed - 8 Apr 2024
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS(R) (edaravone)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 5 Apr 2024
Labcorp Launches Labcorp(R) Plasma Detect(TM) Extending Leadership into Molecular Residual Disease (MRD) Clinical Research
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 3 Apr 2024
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2024
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 2 Apr 2024
NeoImmuneTech Appoints Dr. Luke Oh, Ph.D. as New Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Apr 2024
NEOS Cranial LOOP(TM) Receives FDA Clearance for CustomizedBone(TM) Use
Devices Neurosurgery FDA
 HSMN NewsFeed - 1 Apr 2024
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 29 Mar 2024
RIVANNA(R) Appoints Craig Loomis as Senior Director of Product Management
Devices Radiology Personnel
 HSMN NewsFeed - 29 Mar 2024
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 27 Mar 2024
Medtronic Announces FDA Approval of Newest-Generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 26 Mar 2024
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS(R)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 25 Mar 2024
Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Mar 2024
Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member
Devices Oncology Personnel
 HSMN NewsFeed - 22 Mar 2024
Astellas Receives Positive CHMP Opinion for XTANDI(TM) in Additional Recurrent Early Prostate Cancer Treatment Setting
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Mar 2024
Renibus Announces Leadership Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Mar 2024
ProVerum Announces Completion of Enrollment for the ProVIDE Clinical Study for BPH and First-use of its New Flexible, Steerable Delivery System
Devices Interventional Urology
 HSMN NewsFeed - 19 Mar 2024
Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 18 Mar 2024
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Mar 2024
Dignify Therapeutics Announces Anthony DiTonno as Chief Executive Officer
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 15 Mar 2024
Delcath Systems Announces $7 Million Private Placement
Biopharmaceuticals Drug Delivery Oncology Venture Capital
 HSMN NewsFeed - 14 Mar 2024
Celluma Light Therapy Introduces the RESTORE Hair Therapy System
Biopharmaceuticals Devices Product Launch
 HSMN NewsFeed - 13 Mar 2024
Ventris Medical Receives 510(k) Additional Clearance for Amplify(R) Standalone Bone Graft Putty
Devices FDA
 HSMN NewsFeed - 12 Mar 2024
Emboline Announces That the First One Hundred Patients Have Been Treated in the IDE Study of the Emboliner(R) Full-Body Embolic Protection Catheter to Minimize Stroke Risk From TAVR
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Mar 2024
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA(R) (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2024
PulseCath Achieves MDR CE Certification for iVAC 2L, Paving the Way for Complex High-Risk Percutaneous Coronary Interventions
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 8 Mar 2024
U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Mar 2024
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2024
Sionna Therapeutics Announces $182 Million Series C Financing to Advance Clinical Development of Novel Small Molecules in Cystic Fibrosis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Mar 2024
ADI Announces U.S. FDA 510(k) Clearance and the Commercial Launch of Sensinel by Analog Devices(TM) Cardiopulmonary Management (CPM) System
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 5 Mar 2024
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 4 Mar 2024
Insightec's Groundbreaking Transcranial MR-Guided Focused Ultrasound (MRgFUS) Approved for Additional Reimbursement for Essential Tremor in Germany
Devices Neurology Reimbursement
 HSMN NewsFeed - 4 Mar 2024
Mallinckrodt Announces Appointment of Paul O'Neill as Executive Vice President, Quality & Operations, Specialty Brands
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2024
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar(R) Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector
Devices Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Mar 2024
Boston Scientific Receives FDA Approval for the AGENT(TM) Drug-Coated Balloon
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 29 Feb 2024
Spatz Medical Marks Milestone: Spatz3 Adjustable Gastric Balloon Launches in the U.S. in March 2024
Devices Gastroenterology Product Launch
 HSMN NewsFeed - 28 Feb 2024
Bexion Pharmaceuticals, Inc. Appoints Dr. Tariq Arshad as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Feb 2024
Baird Medical Expands Presence in the United States
Devices Oncology Personnel
 HSMN NewsFeed - 27 Feb 2024
Dave Hickey Announces Intent to Retire from BD
Diagnostics Personnel
 HSMN NewsFeed - 27 Feb 2024
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-520
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Feb 2024
Study Using IceCure's ProSense(R) Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer
Devices Oncology
 HSMN NewsFeed - 23 Feb 2024
BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 22 Feb 2024
NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation
Devices Cardiology Personnel
 HSMN NewsFeed - 22 Feb 2024
Zimmer Biomet Receives FDA Clearance for ROSA(R) Shoulder System - the World's First Robotic Assistant for Shoulder Replacement Surgery
Devices Orthopaedic FDA
 HSMN NewsFeed - 22 Feb 2024
Lancet Digital Health Study Confirms MAGENTIQ-COLO(TM) AI-aided Colonoscopy Technology Improves Adenoma Detection Rates
Devices Gastroenterology
 HSMN NewsFeed - 21 Feb 2024
Sira Medical Wins FDA Clearance for Augmented Reality Preoperative Surgical Planning Software
Devices Surgery FDA
 HSMN NewsFeed - 21 Feb 2024
Zynex Introduces New Products
Devices Orthopaedic Pain Management Product Launch
 HSMN NewsFeed - 21 Feb 2024
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2024
Avidity Biosciences Receives FDA Rare Pediatric Disease Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy in People with Mutations Amenable to Exon 44 Skipping
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Feb 2024
Fusion Pharmaceuticals Enters into Exclusive Worldwide License Agreement with Heidelberg University and Euratom for Actinium-Based PSMA Targeted Radiotherapy
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 15 Feb 2024
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Feb 2024
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 14 Feb 2024
Efemoral Medical Granted Breakthrough Device Designation
Devices Interventional FDA
 HSMN NewsFeed - 14 Feb 2024
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 12 Feb 2024
AbbVie Completes Acquisition of ImmunoGen
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 9 Feb 2024
YS Biopharma Announces US$40 Million Private Placement Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Feb 2024
PreludeDx Appoints Chris Emery, VP of Strategic Marketing and Business Development
Diagnostics Oncology Personnel
 HSMN NewsFeed - 7 Feb 2024
Innova Vascular Announces Successful Early Commercial Use of Laguna Thrombectomy System(TM) in Patients
Devices Interventional
 HSMN NewsFeed - 6 Feb 2024
Zynex Receives FDA Clearance for its Next Generation NMES Device
Devices FDA
 HSMN NewsFeed - 6 Feb 2024
FDA Clears Groundbreaking Corplex P(TM): The First Human Umbilical Cord-Derived Medical Device
Devices Wound Care FDA
 HSMN NewsFeed - 5 Feb 2024
Spyre Therapeutics Appoints Accomplished Biopharma and IBD Leader Mark C. McKenna, Former Chairman, President, and CEO of Prometheus Biosciences, to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2024
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Feb 2024
Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow(R) (EGF(R)) Mapping for use in Atrial Fibrillation Ablation
Devices Cardiology
 HSMN NewsFeed - 31 Jan 2024
Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women
Diagnostics Product Launch
 HSMN NewsFeed - 30 Jan 2024
BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
Diagnostics Oncology
 HSMN NewsFeed - 29 Jan 2024
IceCure Medical's Breast Cryoablation Gains Prominence in the U.S., as Society of Interventional Oncology Annual Meeting Features its First Breast Cryoablation Master Class
Devices Oncology
 HSMN NewsFeed - 29 Jan 2024
Introducing Sechrist's Innovative eHEAL and 3300HM Hyperbaric Chamber
Devices Product Launch
 HSMN NewsFeed - 25 Jan 2024
Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife(R) System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions
Devices Oncology
 HSMN NewsFeed - 24 Jan 2024
ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 23 Jan 2024
FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 22 Jan 2024
CalciMedica Announces Private Placement of up to Approximately $55 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Jan 2024
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Progressive Multiple Sclerosis
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 18 Jan 2024
Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert(R) Xpress MVP
Diagnostics FDA
 HSMN NewsFeed - 17 Jan 2024
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 16 Jan 2024
Orlucent Demonstrates Accurate, Non-Invasive Detection in vivo of Melanoma-Related Activity Using First-in-Kind Handheld Mole Imaging System
Devices Dermatology
 HSMN NewsFeed - 15 Jan 2024
NeoImmuneTech Welcomes a New President for its Development and Business
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Jan 2024
Darmiyan Receives FDA Approval for BrainSee, the First Prognostic Test for Predicting Likelihood of Progression to Alzheimer's Dementia
Diagnostics Neurology FDA
 HSMN NewsFeed - 11 Jan 2024
Zeta Surgical's Mixed Reality Navigation System Receives FDA Special 510(k) Clearance for Expanded Functionality
Devices Neurosurgery FDA
 HSMN NewsFeed - 10 Jan 2024
Providence Medical Technology Announces FDA Clearance of CAVUX(R) FFS-LX Lumbar Facet Fixation System for 1- and 2-Level Lumbar Spinal Fusion
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 9 Jan 2024
TORL BioTherapeutics Announces Appointment of Mark J. Alles as Chairman and Chief Executive Officer; Highlights Significant Progress of its Oncology Clinical Programs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Jan 2024
Medtronic Diabetes announces world's first approval for MiniMed(TM) 780G System with Simplera Sync(TM) disposable, all-in-one sensor
Devices Monitoring Regulatory
 HSMN NewsFeed - 5 Jan 2024
Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 4 Jan 2024
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect(TM)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 2 Jan 2024
Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval
Devices Regulatory FDA Reimbursement
 HSMN NewsFeed - 28 Dec 2023
HR Pharmaceuticals, Inc. receives exclusive commercialization rights to Poiesis Medical's Dual Balloon Catheter technology in North America
Devices Licensing
 HSMN NewsFeed - 27 Dec 2023
Lilly Completes Acquisition of POINT Biopharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Dec 2023
Amgen Provides Regulatory Update on Status of Lumakras(R) (Sotorasib)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Dec 2023
FeelTect secures €1.5 million investment for connected wound treatment technology
Devices Wound Care Monitoring Venture Capital
 HSMN NewsFeed - 18 Dec 2023
NeuExcell's AAV Gene Therapy for Malignant Glioma Granted Orphan Drug Designation by FDA
Regenerative Medicine Neurosurgery Oncology FDA
 HSMN NewsFeed - 15 Dec 2023
CymaBay Submits New Drug Application to FDA for Seladelpar for the Treatment of Primary Biliary Cholangitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Dec 2023
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Myasthenia Gravis
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
CT
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.